Impact of nomenclature as metabolic associated steatotic liver disease on steatotic liver disease prevalence and screening: a prospective population survey in Asians
Journal of Gastroenterology and Hepatology · 2024
DOI: 10.1111/jgh.16554 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gastroenterology and Hepatology, 2024. Verfasst von Tingfeng Wu und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China. Hauptthemen laut MEDLINE: Terminology as Topic, Asian People. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Basic and Applied Basic Research Foundation of Guangdong Province, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Background and Aim The introduction of the latest nomenclature, metabolic associated steatotic liver disease (MASLD), proposed by the multi‐society without Asian society consensus statement, aims to redefine the diagnostic criteria for metabolic associated fatty liver disease (MAFLD). However, its effect on the epidemiology in Asia remains unclear.
Method
We conducted a population‐based cross‐sectional survey on fatty liver disease using multistage stratified random sampling of participants from Guangzhou, a representative area in China (ChiCTR2000033376). Demographic, socioeconomic, lifestyle, and laboratory data were collected. Hepatic steatosis and the severity of fibrosis were assessed using FibroScan.
Results
A total of 7388 individuals were recruited, the proportion of which meeting the definitions for nonalcoholic fatty liver disease (NAFLD), MAFLD, and MASLD were 2359 (31.9%), 2666 (36.1%), and 2240 (30.3%), respectively. One hundred and twenty (1.6%) patients had cryptogenic SLD, and 537 (7.3%) patients were diagnosed with MetALD. MASLD did not significantly differ from NAFLD and MAFLD, except that MAFLD patients had a lower proportion of males, hypertension, and diabetes and were less likely to consume tea ( P < 0.05). Both cryptogenic SLD and MASLD non‐MAFLD patients exhibited milder hepatic steatosis and a lower frequency of liver injury than NAFLD, MAFLD, or MASLD patients (all P < 0.05). An increased HOMA‐IR (adjusted OR: 1.33, 95% CI: 1.10–2.03) was associated with higher risk of moderate‐to‐severe steatosis for MASLD non‐MAFLD patients, while consuming more cups of tea ( P for trend = 0.015) showed inverse associations.
Conclusion
Irrespective of terminology used is that fatty liver disease is highly prevalent in the Han Chinese population. Differences in insulin resistance and lifestyle risk factors are associated with redefinition disparities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
- Department of Gastroenterology, Guangzhou University of Traditional Chinese Medicine Affiliated Foshan Hospital of Traditional Chinese Medicine, Foshan, China.
- Department of Health Care Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
- Department of Health Care Center, Guangdong Provincial People's Hospital Affiliated Pingzhou Hospital, Foshan, China.
- Department of Health Care Center, Yunfu People's Hospital, Yunfu, China.
- Department of Health Care Center, South China University of Technology Affiliated Nanhai People's Hospital, Foshan, China.
ORCID-Profile: Bihui Zhong
Förderung
- National Natural Science Foundation of China
- Basic and Applied Basic Research Foundation of Guangdong Province
- China Postdoctoral Science Foundation
Zitieren
APA
Wu, T., Ye, J., Mo, S., Ye, M., Li, X., Li, Q., Wang, W., Zheng, Q., Luo, K., Zhang, Y., Tu, S., Che, D., Gong, R., Chen, X., Miu, R., Shao, C., Sun, Y., & Zhong, B. (2024). Impact of nomenclature as metabolic associated steatotic liver disease on steatotic liver disease prevalence and screening: a prospective population survey in Asians. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.16554
Vancouver
Wu T, Ye J, Mo S, Ye M, Li X, Li Q, et al. Impact of nomenclature as metabolic associated steatotic liver disease on steatotic liver disease prevalence and screening: a prospective population survey in Asians. Journal of Gastroenterology and Hepatology. 2024. doi:10.1111/jgh.16554
BibTeX
@article{Wu2024,
author = {Wu, Tingfeng and Ye, Junzhao and Mo, Suilin and Ye, Miaosheng and Li, Xiaoyi and Li, Qing and Wang, Wengeng and Zheng, Qiaocong and Luo, Ke and Zhang, Yi and Tu, Shouwei and Che, Daituan and Gong, Rulong and Chen, Xing and Miu, Rong and Shao, Congxiang and Sun, Yanhong and Zhong, Bihui},
title = {Impact of nomenclature as metabolic associated steatotic liver disease on steatotic liver disease prevalence and screening: a prospective population survey in Asians},
journal = {Journal of Gastroenterology and Hepatology},
year = {2024},
doi = {10.1111/jgh.16554}
}
EUVIMED